BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36700974)

  • 1. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer.
    Kong F; Ye Q; Xiong Y
    Funct Integr Genomics; 2023 Jan; 23(1):48. PubMed ID: 36700974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction.
    Gong L; Luo J; Zhang Y; Yang Y; Li S; Fang X; Zhang B; Huang J; Chow LK; Chung D; Huang J; Huang C; Liu Q; Bai L; Tiu YC; Wu P; Wang Y; Tsao GS; Kwong DL; Lee AW; Dai W; Guan XY
    Nat Commun; 2023 Apr; 14(1):1912. PubMed ID: 37024479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
    Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
    Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD70-CD27 axis in oncology: the new kids on the block.
    Flieswasser T; Van den Eynde A; Van Audenaerde J; De Waele J; Lardon F; Riether C; de Haard H; Smits E; Pauwels P; Jacobs J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):12. PubMed ID: 34991665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
    Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP
    J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
    Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
    J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
    Arroyo Hornero R; Georgiadis C; Hua P; Trzupek D; He LZ; Qasim W; Todd JA; Ferreira RC; Wood KJ; Issa F; Hester J
    Commun Biol; 2020 Jul; 3(1):375. PubMed ID: 32665635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.
    Tran-Nguyen TK; Xue J; Feghali-Bostwick C; Sciurba FC; Kass DJ; Duncan SR
    Am J Respir Cell Mol Biol; 2020 Aug; 63(2):255-265. PubMed ID: 32320626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.
    Inaguma S; Lasota J; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; Okoń K; Biernat W; Schrump DS; Hassan R; Kasai K; Miettinen M; Ikeda H
    J Pathol; 2020 Feb; 250(2):205-216. PubMed ID: 31639216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
    Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
    J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD70 expression in tumor-associated fibroblasts predicts worse survival in colorectal cancer patients.
    Inoue S; Ito H; Tsunoda T; Murakami H; Ebi M; Ogasawara N; Kasugai K; Kasai K; Ikeda H; Inaguma S
    Virchows Arch; 2019 Oct; 475(4):425-434. PubMed ID: 30980190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.
    Jaeger-Ruckstuhl CA; Lo Y; Fulton E; Waltner OG; Shabaneh TB; Simon S; Muthuraman PV; Correnti CE; Newsom OJ; Engstrom IA; Kanaan SB; Bhise SS; Peralta JMC; Ruff R; Price JP; Stull SM; Stevens AR; Bugos G; Kluesner MG; Voillet V; Muhunthan V; Morrish F; Olson JM; Gottardo R; Sarthy JF; Henikoff S; Sullivan LB; Furlan SN; Riddell SR
    Immunity; 2024 Feb; 57(2):287-302.e12. PubMed ID: 38354704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.
    Benhamouda N; Sam I; Epaillard N; Gey A; Phan L; Pham HP; Gruel N; Saldmann A; Pineau J; Hasan M; Quiniou V; Nevoret C; Verkarre V; Libri V; Mella S; Granier C; Broudin C; Ravel P; De Guillebon E; Mauge L; Helley D; Jabla B; Chaput N; Albiges L; Katsahian S; Adam J; Mejean A; Adotevi O; Vano YA; Oudard S; Tartour E
    Clin Cancer Res; 2022 Nov; 28(22):4983-4994. PubMed ID: 36067339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell-Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses.
    O'Neill RE; Du W; Mohammadpour H; Alqassim E; Qiu J; Chen G; McCarthy PL; Lee KP; Cao X
    J Immunol; 2017 Nov; 199(10):3700-3710. PubMed ID: 29046346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.
    Nagato T; Komatsuda H; Hayashi R; Takahara M; Ujiie N; Kosaka A; Ohkuri T; Oikawa K; Sato R; Wakisaka R; Kono M; Yamaki H; Ohara K; Kumai T; Kishibe K; Katada A; Hayashi T; Kobayashi H
    Cancer Sci; 2024 Apr; 115(4):1073-1084. PubMed ID: 38279834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural delineation and phase-dependent activation of the costimulatory CD27:CD70 complex.
    Liu W; Maben Z; Wang C; Lindquist KC; Li M; Rayannavar V; Lopez Armenta I; Nager A; Pascua E; Dominik PK; Oyen D; Wang H; Roach RC; Allan CM; Mosyak L; Chaparro-Riggers J
    J Biol Chem; 2021 Oct; 297(4):101102. PubMed ID: 34419446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CD8
    Zhao S; Zhang Y; Huang G; Luo W; Li Y; Xiao Y; Zhou M; Li Y; Lai J; Li Y; Li B
    Blood Cells Mol Dis; 2019 Jul; 77():34-42. PubMed ID: 30953940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.
    Ortiz-Cuaran S; Swalduz A; Foy JP; Marteau S; Morel AP; Fauvet F; De Souza G; Michon L; Boussageon M; Gadot N; Godefroy M; Léon S; Tortereau A; Mourksi NE; Leonce C; Albaret MA; Dongre A; Vanbervliet B; Robert M; Tonon L; Pommier RM; Hofman V; Attignon V; Boyault S; Audoynaud C; Auclair J; Bouquet F; Wang Q; Ménétrier-Caux C; Pérol M; Caux C; Hofman P; Lantuejoul S; Puisieux A; Saintigny P
    Eur J Cancer; 2022 Jul; 169():106-122. PubMed ID: 35550950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells.
    Schmitter D; Bolliger U; Hallek M; Pichert G
    Br J Haematol; 1999 Jul; 106(1):64-70. PubMed ID: 10444164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.
    Beishuizen CR; Kragten NA; Boon L; Nolte MA; van Lier RA; van Gisbergen KP
    J Immunol; 2009 Nov; 183(10):6442-51. PubMed ID: 19864607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.